Farahnak Assadi to Enzyme Inhibitors
This is a "connection" page, showing publications Farahnak Assadi has written about Enzyme Inhibitors.
Connection Strength
0.198
-
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid-resistant nephrotic syndrome. Pharmacotherapy. 2022 09; 42(9):690-696.
Score: 0.198